Pressure Ulcer Diagnostics Market Size Expected To Generate USD 1.2 Bn By 2027
The global Pressure Ulcer Diagnostics market gathered revenue around USD 881.10 Million in 2020 and market is set to grow USD USD 1.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 10% during the prediction period 2021 to 2027.
Pressure ulcer diagnostics are devices used in diagnosis and detection of pressure ulcer in adults and elderly patient population. Pressure ulcers are also called bedsores or pressure injuries. These are caused by pressure on the skin and lead to damage to the underlying skin or tissue. There are four stages of pressure ulcer wounds: stage 1, stage 2, stage 3, and stage 4. Various invasive and non-invasive diagnostic tools are available, which are considered standard method of diagnosis of pressure ulcer. Blood tests are most commonly used for detection of bacteria load and location.
Based on diagnostic test, the global pressure ulcer diagnostics market has been classified into imaging technique, microbiological tests, and others. The imaging technique segment accounted for major market share in 2020 due to adoption of non-invasive tools such as fluorescent imaging, photoacoustic imaging, biomarkers, magnetic resonance, computed tomography, and other imaging technologies. Technological advancements have led to the innovation of new diagnosis techniques, which is expected to drive the segment during the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Pressure Ulcer Diagnostics market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Pressure Ulcer Diagnostics market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Pressure Ulcer Diagnostics market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Pressure Ulcer Diagnostics Market: Prominent Regions
In terms of region, the global pressure ulcer diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pressure ulcer diagnostics market in 2020, followed by Europe and Asia Pacific. Increase in patients suffering from pressure ulcers, rise in expenditure of the U.S. Government on management of pressure ulcers, surge in admissions of patients in ICU, and increase in baby boomers in the U.S. propel the market in North America during the forecast period.
The pressure ulcer diagnostics market in Asia Pacific is expected to expand at a higher CAGR from 2021 to 2027. Increase in geriatric patient population at risk of developing pressure ulcers and rise in prevalence of pressure ulcers in ICU admitted patients and long-term care older patients in hospitals and nursing homes are likely to boost the growth of the pressure ulcer diagnostic market in the region over the next few years.
| Report Highlights | Details |
| Market Size | US$ 1.2 Billion by 2027 |
| Growth Rate | CAGR of 10% From 2021 to 2027 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2027 |
| Segments Covered | Product,Wound,Modality |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | IR-MED, Bruin Biometrics, LLC, Canon Medical Systems Corporation, Esaote SPA, Fonar Corporation, Bruker Corporation, FUJIFILM Healthcare Corporation, GE Healthcare, Arjo, Cyberdyne, Inc., and MolecuLight, Inc |
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Pressure Ulcer Diagnostics Market include: IR-MED, Bruin Biometrics, LLC, Canon Medical Systems Corporation, Esaote SPA, Fonar Corporation, Bruker Corporation, FUJIFILM Healthcare Corporation, GE Healthcare, Arjo, Cyberdyne, Inc., and MolecuLight, Inc.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Pressure Ulcer Diagnostics Market: Segmentation
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Pressure Ulcer Diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Pressure Ulcer Diagnostics market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Pressure Ulcer Diagnostics markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Pressure Ulcer Diagnostics market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pressure Ulcer Diagnostics Market, By Product
7.1. Pressure Ulcer Diagnostics Market, by Product, 2021-2027
7.1.1. Imaging Technique
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Magnetic Resonance Imaging (MRI)
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Magnetic Resonance Imaging (MRI)
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Computed Tomography (CT) Scan
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Fluorescence Imaging
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Ultrasound Imaging
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Others
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Microbiological Tests
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Biopsy
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. Blood Tests
7.1.10.1. Market Revenue and Forecast (2016-2027)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Pressure Ulcer Diagnostics Market, By Wound
8.1. Pressure Ulcer Diagnostics Market, by Wound, 2021-2027
8.1.1. Stage 1
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Stage 2
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Stage 3
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Stage 4
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Pressure Ulcer Diagnostics Market, By Modality
9.1. Pressure Ulcer Diagnostics Market, by Modality, 2021-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Home Care Settings
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Nursing homes
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Pressure Ulcer Diagnostics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Wound (2016-2027)
10.1.3. Market Revenue and Forecast, by Modality (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Modality (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Wound (2016-2027)
10.2.3. Market Revenue and Forecast, by Modality (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Modality (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Wound (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Modality (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Wound (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Modality (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Wound (2016-2027)
10.3.3. Market Revenue and Forecast, by Modality (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Modality (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Wound (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Modality (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Wound (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Modality (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Modality (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Wound (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Modality (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Wound (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Modality (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.5.3. Market Revenue and Forecast, by Modality (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Wound (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Modality (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Wound (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Modality (2016-2027)
Chapter 11. Company Profiles
11.1. Modality
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Bruin Biometrics
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. LLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Canon Medical Systems Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Esaote SPA
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Fonar Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bruker Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. FUJIFILM Healthcare Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. GE Healthcare
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Arjo
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers